Smith-Lemli-Opitz syndrome (SLOS) is an inborn error of metabolism caused by defective cholesterol biosynthesis. Mutations within the gene encoding 7-dehydrocholesterol reductase (DHCR7), the last enzyme in the pathway, lead to the accumulation of 7-dehydrocholesterol (7-DHC) in the brain tissue and blood of the SLOS patients. The objective of this study was to determine the consequences of the accumulation of an immediate cholesterol precursor, 7-DHC and its oxysterol metabolite, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), in the brain tissue of Dhcr7-KO mouse, a model for SLOS. We found that cholesterol, 7-DHC and DHCEO show region-specific distribution, suggesting that the midbrain and the cortex are the primary sites of vulnerability. We also report that neurons are ten fold more susceptible to a 7-DHC-derived oxysterol mixture than glial cells, and that DHCEO accelerates differentiation and arborization of cortical neurons. The overall results suggest that 7-DHC oxidative metabolites are critical contributors to altered neural development in SLOS. The future studies will test if antioxidant supplementation will ameliorate some of the clinical symptoms associated with this devastating disease.
Introduction
Cholesterol is an essential structural component of the central nervous system (CNS). Compared to the rest of the body, the brain contains proportionally the highest amount of cholesterol (Dietschy and Turley, 2001 ). However, cholesterol shows a highly regional distribution in the CNS, with the highest expression observed in the hippocampus and cortex (Korade et al., 2007) . Smith-Lemli-Opitz Syndrome (SLOS) is a developmental disorder that arises from mutations in the gene encoding 7-dehydrocholesterol reductase (DHCR7), the last step in the cholesterol biosynthesis pathway (Irons et al., 1993; Tierney et al., 2000) . The mutation leads to reduced levels of cholesterol and accumulation of 7-dehydrocholesterol (7-DHC) (Irons et al., 1993; Tierney et al., 2000) . We recently demonstrated that 7-DHC is the most readily oxidizable lipid molecule in free radical-mediated oxidation reactions (Xu et al., 2009 (Xu et al., , 2010 . As a result, 7-DHC is oxidized, giving rise to a number of metabolites, namely oxysterols (Xu et al., 2010) . One of these metabolites, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO) (Xu et al., 2011a) ( Fig. 1) , shows significant accumulation in fibroblasts of SLOS patients and in the brain of a SLOS mouse model (Xu et al., 2011a) , raising the possibility that it might significantly contribute to SLOS pathophysiology in the brain of patients.
The regional differences in 7-DHC, DHCEO, and their physiological effects on brain development/function are not known to date. To better understand the mechanism by which 7-DHC and its metabolite, DHCEO, might contribute to the altered development and brain dysfunction in SLOS, we undertook a series of studies. We determined the distribution of cholesterol, 7-DHC and DHCEO across various brain regions and followed that with assessment of DHCEO effects on neuronal and glial cells.
Materials and methods
Dhcr7-KO Mice-Dhcr7-KO (Dhcr7 tm1Gst/J ) mice were purchased from Jackson Laboratories (catalog # 007453). The mice were kept and bred in Division of Animal Care facilities at the Vanderbilt University. For the analysis of different brain regions embryos were dissected from pregnant females at E20 and the tail was removed from each embryo for genotyping. The genomic DNA from mouse tails was extracted using REDExtract-N-Amp Tissue PCR kit (Sigma-Aldrich). Genotyping was performed using the following PCR primers: forward -ggatcttctgagggcagcctt, reverse -tctgaacccttggctgatca, neo: ctagaccgcggctagagaat. Embryonic heads were removed, brains and specific brain regions dissected and instantly frozen in pre-cooled 2-methylbutane (on dry ice) and stored at − 80°C until lipid extraction. We collected 5 litters of mice and compared specific brain regions in WT and KO mice Neurobiology of Disease 45 (2012) 923-929 
